BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 19682430)

  • 1. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
    Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
    Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G.
    Chen Y; Liu W; Chao T; Zhang Y; Yan X; Gong Y; Qiang B; Yuan J; Sun M; Peng X
    Cancer Lett; 2008 Dec; 272(2):197-205. PubMed ID: 19013014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
    Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
    Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells.
    Qiang R; Wang F; Shi LY; Liu M; Chen S; Wan HY; Li YX; Li X; Gao SY; Sun BC; Tang H
    Int J Biochem Cell Biol; 2011 Apr; 43(4):632-41. PubMed ID: 21216304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.
    Hiyoshi Y; Kamohara H; Karashima R; Sato N; Imamura Y; Nagai Y; Yoshida N; Toyama E; Hayashi N; Watanabe M; Baba H
    Clin Cancer Res; 2009 Mar; 15(6):1915-22. PubMed ID: 19276261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pdcd4, a colon cancer prognostic that is regulated by a microRNA.
    Allgayer H
    Crit Rev Oncol Hematol; 2010 Mar; 73(3):185-91. PubMed ID: 19836969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
    Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
    Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
    Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDCD4 inhibits the malignant phenotype of ovarian cancer cells.
    Wei ZT; Zhang X; Wang XY; Gao F; Zhou CJ; Zhu FL; Wang Q; Gao Q; Ma CH; Sun WS; Fu QZ; Chen YH; Zhang LN
    Cancer Sci; 2009 Aug; 100(8):1408-13. PubMed ID: 19493270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
    Zhu Q; Wang Z; Hu Y; Li J; Li X; Zhou L; Huang Y
    Oncol Rep; 2012 May; 27(5):1660-8. PubMed ID: 22322403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells.
    Long MJ; Wu FX; Li P; Liu M; Li X; Tang H
    Cancer Lett; 2012 Nov; 324(2):186-96. PubMed ID: 22634495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
    Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
    Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression.
    Rouas R; Fayyad-Kazan H; El Zein N; Lewalle P; Rothé F; Simion A; Akl H; Mourtada M; El Rifai M; Burny A; Romero P; Martiat P; Badran B
    Eur J Immunol; 2009 Jun; 39(6):1608-18. PubMed ID: 19408243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
    Sun Z; Li S; Kaufmann AM; Albers AE
    Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development.
    Yamamichi N; Shimomura R; Inada K; Sakurai K; Haraguchi T; Ozaki Y; Fujita S; Mizutani T; Furukawa C; Fujishiro M; Ichinose M; Shiogama K; Tsutsumi Y; Omata M; Iba H
    Clin Cancer Res; 2009 Jun; 15(12):4009-16. PubMed ID: 19509156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
    Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
    Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.
    Wu Q; Jin H; Yang Z; Luo G; Lu Y; Li K; Ren G; Su T; Pan Y; Feng B; Xue Z; Wang X; Fan D
    Biochem Biophys Res Commun; 2010 Feb; 392(3):340-5. PubMed ID: 20067763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
    Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
    J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
    Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.